Related references
Note: Only part of the references are listed.Drug Design Strategies to Avoid Resistance in Direct-Acting Antivirals and Beyond
Ashley N. Matthew et al.
CHEMICAL REVIEWS (2021)
Treatment failure with DAA therapy: Importance of resistance
Christoph Sarrazin
JOURNAL OF HEPATOLOGY (2021)
Molecular and Structural Mechanism of Pan-Genotypic HCV NS3/4A Protease Inhibition by Glecaprevir
Jennifer Timm et al.
ACS CHEMICAL BIOLOGY (2020)
Avoiding Drug Resistance by Substrate Envelope-Guided Design: Toward Potent and Robust HCV NS3/4A Protease Inhibitors
Ashley N. Matthew et al.
MBIO (2020)
Prevalence of resistance-associated substitutions and retreatment of patients failing a glecaprevir/pibrentasvir regimen
Adolfo de Salazar et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2020)
Discovery of BMS-986144, a Third-Generation, Pan-Genotype NS3/4A Protease Inhibitor for the Treatment of Hepatitis C Virus Infection
Li-Qiang Sun et al.
JOURNAL OF MEDICINAL CHEMISTRY (2020)
Surveying biomolecular frustration at atomic resolution
Mingchen Chen et al.
NATURE COMMUNICATIONS (2020)
EASL recommendations on treatment of hepatitis C: Final update of the series
Jean-Michel Pawlotsky et al.
JOURNAL OF HEPATOLOGY (2020)
Resistance outside the substrate envelope: hepatitis C NS3/4A protease inhibitors
Aysegul Ozen et al.
CRITICAL REVIEWS IN BIOCHEMISTRY AND MOLECULAR BIOLOGY (2019)
In Vitro Susceptibility of Hepatitis C Virus Genotype 1 through 6 Clinical Isolates to the Pangenotypic NS3/4A Inhibitor Voxilaprevir
Bin Han et al.
JOURNAL OF CLINICAL MICROBIOLOGY (2019)
Evolutionary Pathways to Persistence of Highly Fit and Resistant Hepatitis C Virus Protease Inhibitor Escape Variants
Sanne Brun Jensen et al.
HEPATOLOGY (2019)
Patterns of Resistance-Associated Substitutions in Patients With Chronic HCV Infection Following Treatment With Direct-Acting Antivirals
Julia Dietz et al.
GASTROENTEROLOGY (2018)
Fluorine and Fluorinated Motifs in the Design and Application of Bioisosteres for Drug Design
Nicholas A. Meanwell
JOURNAL OF MEDICINAL CHEMISTRY (2018)
Molecular Mechanism of Resistance in a Clinically Significant Double-Mutant Variant of HCV NS3/4A Protease
Ashley N. Matthew et al.
STRUCTURE (2018)
Characterization of HCV resistance from a 3-day monotherapy study of voxilaprevir, a novel pangenotypic NS3/4A protease inhibitor
Eric Lawitz et al.
ANTIVIRAL THERAPY (2018)
In Vitro Antiviral Activity and Resistance Profile of the Next-Generation Hepatitis C Virus NS3/4A Protease Inhibitor Glecaprevir
Teresa I. Ng et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2018)
Hepatitis C Virus NS3/4A Protease Inhibitors Incorporating Flexible P2 Quinoxalines Target Drug Resistant Viral Variants
Ashley N. Matthew et al.
JOURNAL OF MEDICINAL CHEMISTRY (2017)
Structural and Thermodynamic Effects of Macrocyclization in HCV NS3/4A Inhibitor MK-5172
Djade I. Soumana et al.
ACS CHEMICAL BIOLOGY (2016)
Hepatitis C virus NS3/4a protease inhibitors
John A. McCauley et al.
CURRENT OPINION IN PHARMACOLOGY (2016)
Hepatitis C Virus Resistance to Direct-Acting Antiviral Drugs in Interferon-Free Regimens
Jean-Michel Pawlotsky
GASTROENTEROLOGY (2016)
The importance of resistance to direct antiviral drugs in HCV infection in clinical practice
Christoph Sarrazin
JOURNAL OF HEPATOLOGY (2016)
2015 Philip S. Portoghese Medicinal Chemistry Lectureship. Curing Hepatitis C Virus Infection with Direct-Acting Antiviral Agents: The Arc of a Medicinal Chemistry Triumph
Nicholas A. Meanwell
JOURNAL OF MEDICINAL CHEMISTRY (2016)
Discovery of a Potent Acyclic, Tripeptidic, Acyl Sulfonamide Inhibitor of Hepatitis C Virus NS3 Protease as a Back-up to Asunaprevir with the Potential for Once-Daily Dosing
Li-Qiang Sun et al.
JOURNAL OF MEDICINAL CHEMISTRY (2016)
Molecular and Dynamic Mechanism Underlying Drug Resistance in Genotype 3 Hepatitis C NS3/4A Protease
Djade I. Soumana et al.
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY (2016)
P2-Quinazolinones and Bis-Macrocycles as New Templates for Next-Generation Hepatitis C Virus NS3/4a Protease Inhibitors: Discovery of MK-2748 and MK-6325
Michael T. Rudd et al.
CHEMMEDCHEM (2015)
Applications of Fluorine in Medicinal Chemistry
Eric P. Gillis et al.
JOURNAL OF MEDICINAL CHEMISTRY (2015)
Global Distribution and Prevalence of Hepatitis C Virus Genotypes
Jane P. Messina et al.
HEPATOLOGY (2015)
Global epidemiology and genotype distribution of the hepatitis C virus infection
Erin Gower et al.
JOURNAL OF HEPATOLOGY (2014)
Discovery of Hepatitis C Virus NS3-4A Protease Inhibitors with Improved Barrier to Resistance and Favorable Liver Distribution
Benoit Moreau et al.
JOURNAL OF MEDICINAL CHEMISTRY (2014)
Discovery of Danoprevir (ITMN-191/R7227), a Highly Selective and Potent Inhibitor of Hepatitis C Virus (HCV) NS3/4A Protease
Yutong Jiang et al.
JOURNAL OF MEDICINAL CHEMISTRY (2014)
Evaluating the Role of Macrocycles in the Susceptibility of Hepatitis C Virus NS3/4A Protease Inhibitors to Drug Resistance
Akbar Ali et al.
ACS CHEMICAL BIOLOGY (2013)
Efficient Replication of Genotype 3a and 4a Hepatitis C Virus Replicons in Human Hepatoma Cells
Mohsan Saeed et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2012)
MK-5172, a Selective Inhibitor of Hepatitis C Virus NS3/4a Protease with Broad Activity across Genotypes and Resistant Variants
Vincenzo Summa et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2012)
Discovery of Novel Urea-Based Hepatitis C Protease Inhibitors with High Potency against Protease-Inhibitor-Resistant Mutants
Wieslaw M. Kazmierski et al.
JOURNAL OF MEDICINAL CHEMISTRY (2012)
The Molecular Basis of Drug Resistance against Hepatitis C Virus NS3/4A Protease Inhibitors
Keith P. Romano et al.
PLOS PATHOGENS (2012)
PHENIX: a comprehensive Python-based system for macromolecular structure solution
Paul D. Adams et al.
ACTA CRYSTALLOGRAPHICA SECTION D-STRUCTURAL BIOLOGY (2010)
The C-F bond as a conformational tool in organic and biological chemistry
Luke Hunter
BEILSTEIN JOURNAL OF ORGANIC CHEMISTRY (2010)
Discovery of a Potent and Selective Noncovalent Linear Inhibitor of the Hepatitis C Virus NS3 Protease (BI 201335)
Montse Llinas-Brunet et al.
JOURNAL OF MEDICINAL CHEMISTRY (2010)
Drug resistance against HCV NS3/4A inhibitors is defined by the balance of substrate recognition versus inhibitor binding
Keith P. Romano et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2010)
MolProbity: all-atom contacts and structure validation for proteins and nucleic acids
Ian W. Davis et al.
NUCLEIC ACIDS RESEARCH (2007)
Solving structures of protein complexes by molecular replacement with Phaser
Airlie J. McCoy
ACTA CRYSTALLOGRAPHICA SECTION D-STRUCTURAL BIOLOGY (2007)
Structure-activity study on a novel series of macrocyclic inhibitors of the hepatitis C virus NS3 protease leading to the discovery of BILN 2061
M Llinàs-Brunet et al.
JOURNAL OF MEDICINAL CHEMISTRY (2004)
A systematic approach to the optimization of substrate-based inhibitors of the hepatitis C virus NS3 protease:: Discovery of potent and specific tripeptide
M Llinàs-Brunet et al.
JOURNAL OF MEDICINAL CHEMISTRY (2004)
Coot:: model-building tools for molecular graphics
P Emsley et al.
ACTA CRYSTALLOGRAPHICA SECTION D-STRUCTURAL BIOLOGY (2004)
Share Paper
